MeSH tree: D12.776.124.486.485.114.224
The NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The phase II portion of the NRG-HN005 evaluated two experimental treatment ...
Sep 30, 2024
0
26
Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized Phase II/III trial after patients in the ...
Sep 30, 2024
0
24
For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does not differ for those who are anti-CD20-treated and untreated, according to a study published online ...
Sep 26, 2024
0
47
Research at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers also managed ...
Sep 26, 2024
0
31
In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receiving treatment. ...
Sep 25, 2024
0
40
Bacterial infections resulting in enteritis, and sometimes extra-intestinal infections such as sepsis, continue to be a global health concern. A leading cause of diarrheal and extra-intestinal infectious mortality among children ...
Sep 25, 2024
0
25
Monash University researchers have developed a new technique to boost the effectiveness of both traditional and mRNA-based vaccines in animal models.
Sep 23, 2024
0
39
Artificial intelligence and non-antibiotic therapeutic approaches could play a role in tackling antimicrobial resistance (AMR), according to new research.
Sep 23, 2024
0
33
A new study published this week in Molecular Psychiatry by Emory University researchers has revealed a promising new avenue for treating motivational deficits in patients suffering from depression.
Sep 23, 2024
0
143
For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, including one immune checkpoint inhibitor (ICI), tivozanib has efficacy, according to a study published ...
Sep 20, 2024
0
45
